The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; BMS Brazil; Daiichi Sankyo; GlaxoSmithKline; Ipsen; Janssen; MSD
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Janssen
A phase II trial of pembrolizumab combined with platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.
 
Fernando Cotait Maluf
Honoraria - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb Brazil; Janssen Oncology; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb Brazil; Janssen Oncology; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA
 
Karine Trindade
Honoraria - BMS Brazil; Janssen-Cilag; MSD Oncology
Consulting or Advisory Role - Astellas Pharma; Janssen-Cilag; MSD Oncology
Research Funding - BMS Brazil (Inst); Janssen-Cilag (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
 
Daniel D Almeida Preto
No Relationships to Disclose
 
Murilo de Almeida Luz
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen; Medivation; Myovant Sciences; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche
 
Patricia Milhomem Beato
No Relationships to Disclose
 
Diogo Assed Bastos
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; MSD Oncology; MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
 
Anamaria Aranha Camargo
No Relationships to Disclose
 
Cristina Beatriz Cazabuena Bonorino
No Relationships to Disclose
 
Rafaela Gomes de Jesus
No Relationships to Disclose
 
Fernando Monteiro
No Relationships to Disclose
 
Joao Paulo Holanda Soares
No Relationships to Disclose
 
Eduardo Eduardo Werneck De Carvalho
Honoraria - AstraZeneca; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; NOVARTIS; Roche
 
Victor Marcondes Lopes dos Santos
No Relationships to Disclose
 
Gustavo Werutsky
Honoraria - AstraZeneca/MedImmune; Libbs; Merck; Pfizer
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb Brazil (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis; Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech
 
Taiane Francieli Rebelatto
No Relationships to Disclose
 
Andre P. Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche